BioConnection
Martijn Poels currently serves as Chief Financial Officer at BioConnection B.V. since August 2023. Previously, Martijn held the CFO position at Helvoet Rubber & Plastic Technologies from April 2022 to March 2023 and worked as Interim Group Finance Director at Customs Support for a brief period in early 2022. Prior roles include Group Director Finance, Planning & Control at Centrient Pharmaceuticals and various finance leadership positions at DSM Sinochem Pharmaceuticals, Merck, Organon, and Akzo Nobel Catalysts. Martijn Poels's extensive experience in financial management spans multiple industries, with a strong focus on integration following acquisitions and oversight of diverse supply chains and manufacturing networks. Martijn holds an RC/EMFC degree in Finance & Control from Vrije Universiteit Amsterdam and a Master's degree in Industrial Engineering and Management Science from Eindhoven University of Technology.
This person is not in any teams
BioConnection
BioConnection (www.BioConnection.eu) is a Dutch contract services and manufacturing organization for the development and production of injectable (bio)pharmaceutical products. From our FDA and EMA certified facility in Oss we service our global customers. The cornerstones of our CMC services are: Drug Product development, Fill & Finish and freeze-drying at clinical and commercial scale. We also have capabilities for small scale (handfill) for for personalized medicines. We have the means and expertise to bring your invention from the lab bench to the clinic and/or to the market. Our approach ensures a seamless development and manufacturing chain for your product.